Business Information
The group's principal activities are to manufacture and sell pharmaceutical products. The group operates in the following segments namely pharmaceuticals, consumer health care and animal healthcare. The pharmaceuticals segment manufactures and sells branded and generic human ethical pharmaceuticals, biologicals, nutritionals and animal biologicals and pharmaceuticals. These products are sold worldwide primarily to wholesalers, pharmacies, hospitals, physicians, retailers, veterinarians and animal health care institutions. The consumer health care segment manufactures and sells over-the-counter health care products. Principal products include analgesics, cough/cold/allergy remedies, nutritional supplements, herbal products and hemorrhoidal, antacid, asthma and other relief items. Animal health care segment manufactures, distributes and sells animal biological and products.
|
|
Name |
Title
|
Email
|
| Robert Essner | Chmn., CEO | N/A | | Bernard Poussot | Vice Chmn., COO, Pres. | N/A | | Greg Norden | CFO, Sr. VP | N/A | | Jeffrey Keisling | VP - Corporate Information Services, CIO | N/A | | Kenneth Martin | Vice Chmn., CFO | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 20,350,655 | 4,196,706 | | 2005 | 18,755,790 | 3,656,298 | | 2004 | 17,358,028 | 1,233,997
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
